Nevertheless, further work to better outline the criteria for assigning a tumor as PTEN-deficient is needed (e.g., PTEN cellular localization, PTEN conformational state, and the percentage of PTEN-negative prostate epithelial cells) [66,67,68,69]. The gene discussed is PTEN; the disease is neoplasm.